1997
DOI: 10.1002/(sici)1099-1166(199709)12:9<913::aid-gps663>3.0.co;2-d
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
118
1
9

Year Published

2004
2004
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 301 publications
(132 citation statements)
references
References 22 publications
4
118
1
9
Order By: Relevance
“…Others have suggested that dronabinol may have a favorable impact on anorexia and disturbed behavior in patients with Alzheimer's disease (Volicer et al 1997). The biometric data obtained in the present study corroborate these findings.…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…Others have suggested that dronabinol may have a favorable impact on anorexia and disturbed behavior in patients with Alzheimer's disease (Volicer et al 1997). The biometric data obtained in the present study corroborate these findings.…”
Section: Discussionsupporting
confidence: 90%
“…In addition, although our patients were in stable medical condition at the time of the trial, some of them had substantial comorbidities, such as moderate heart or kidney disease. Earlier trials of oral dronabinol have reported dosedependent side effects, including drowsiness, dizziness, dysphoria, hypotension, hallucinations, headaches, and palpitations Svendsen et al 2004;Tramer et al 2001;Volicer et al 1997). It is reassuring to note that we were unable to observe any side effects due to dronabinol or any aggravation of heart or kidney disease in our patients.…”
Section: Discussioncontrasting
confidence: 43%
See 1 more Smart Citation
“…Encouraging data have emerged that Dronabinol, an oil-based D 9 -THC, improves disturbed behavior in AD patients [365,366]. The proposed site of action of cannabinoids are the NMDA receptors, possibly via inhibition of presynaptic Ca 2+ entry and subsequent inhibition of excessive glutaminergic synaptic activity [367,368].…”
Section: Targeting Trophic Factor and Receptor-mediated Pathways In Amentioning
confidence: 99%
“…Die Autoren schlussfolgern, dass Dronabinol bei Patienten mit Morbus Alzheimer eine mögliche neue Therapieoption darstellt, und zwar nicht nur zur Behandlung einer Anorexie, sondern auch um z. B. Konzentrations-und Merkfähigkeit zu verbessern[23].…”
unclassified